The SLITRK1 gene helps guide how nerve cells grow and connect in the brain, especially in pathways involved in movement, attention, and behavior. This gene plays an important role in helping brain cells form stable connections, so if it does not work as expected, signaling between those cells may be less well organized. Some variants in the SLITRK1 gene have been linked to a higher chance of conditions such as Tourette syndrome or related repetitive behaviors. These links are not a diagnosis, and their effects can vary from person to person.
What is a gene?
A gene is a section of DNA that gives your cells instructions for making molecules or directing activities in the body. Some genes provide the directions for proteins, which do much of the work inside cells. Others mainly regulate when a process happens, where it happens, and how active it is. Taken together, genes affect how your body develops and works, and they can influence your response to food, stress, and medicines. More detail on this topic is available in the LearnHub.
Overview
SLITRK1Gene function
What if the gene works
The SLITRK1 gene helps brain cells grow and form connections. Its protein helps organize synapses, the contact points where nerve cells signal each other.
Risk
What if the gene does not work
Milder to more severe variants in the SLITRK1 gene can reduce how well developing nerve cells extend branches and form synaptic connections. This may alter signaling between brain cells.
Treatment
What does that mean for your treatment
No SLITRK1-specific treatment or drug selection approach is currently established for pathogenic variants in the SLITRK1 gene. Care is guided by a person’s symptoms and diagnosis, using standard treatments rather than the gene result itself.
Conditions associated with SLITRK1
Gene function
What if the gene works
Your brain depends on carefully timed growth and communication between nerve cells. The SLITRK1 gene helps guide how these cells extend their branches and make contact with one another. This supports how brain cells grow and connect into organized networks.
The SLITRK1 gene helps developing nerve cells grow out their early branches. These branches later form the long and short extensions cells use to send and receive signals.
Its protein sits on the cell surface and helps nerve cells form communication points called synapses. These are the places where one cell passes a message to the next.
During development, the SLITRK1 gene helps organize where nerve cell branches and connections are placed. This supports orderly wiring of brain circuits as cells mature.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental factors. Many variants do not cause any noticeable effects and represent natural genetic variation. At times, though, a variant can change how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLITRK1 gene can change the protein’s shape, stability, or delivery to the nerve cell surface, which may weaken how it interacts with nearby cell proteins and organizes synapse development. This helps explain how variants influence the SLITRK1 gene's function at a cellular level. Some changes have milder effects, while more severe variants can markedly reduce protein activity or leave little working protein.
How variants are linked to conditions
At this stage, variants in the SLITRK1 gene do not yet have a broadly confirmed link to a specific health condition, although research on SLITRK1 gene variants and health conditions is still developing. Anyone with a confirmed SLITRK1-related diagnosis should rely on guidance from their doctor or genetic counselor for interpretation.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most variants do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk specifically related to the SLITRK1 gene. Changes in SLITRK1 have been studied in conditions affecting tics, behavior, and mood, but risk appears to be shaped by many genes and life factors together.
Inheritance of SLITRK1 variants
There is not yet a broadly confirmed, disease-specific Mendelian pattern for inheritance of the SLITRK1 gene variants, and research on SLITRK1 gene inheritance is still developing. In families, a variant in the SLITRK1 gene may be passed down from either parent, but this alone does not establish a predictable dominant or recessive pattern for a specific condition. The SLITRK1 gene is located on chromosome 13, which is an autosome, so everyone inherits one copy from each parent.
What does my SLITRK1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for SLITRK1, though this can change as research develops. If you have a specific SLITRK1 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the SLITRK1 gene analyzes DNA from a blood sample, saliva, or a cheek swab to look for variants. Results may show that a variant is present, absent, or not yet clearly understood, and testing is often done as part of a broader gene panel.
When should I consider getting a genetic test?
There is not yet a broadly established, SLITRK1-specific clinical reason for testing. Decisions about testing are usually based on symptoms and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body works. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some people break down a drug faster or slower, while others are more or less sensitive to its effects. These inherited differences are common and can influence how much benefit a medicine gives or how likely side effects are. Other factors, such as age, liver and kidney function, and other medicines, also play a part.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. More about this topic is available in the LearnHub.
Drugs influenced by the SLITRK1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have concerns about symptoms, side effects, or changes in how a treatment is affecting you, it is best to discuss them with your doctor.
History
The SLITRK1 gene entered medical research in the early 2000s as scientists were mapping a family of related genes active in the nervous system. Public and scientific interest rose in 2005, when a study reported rare SLITRK1 variants in some people with Tourette syndrome. From these first observations, research expanded steadily. Later studies found a more complex picture, with some results not repeating consistently across larger groups, which shifted SLITRK1 from a possible single major cause to one part of a broader genetic story. That history made SLITRK1 an early example of how gene discovery can open new clues while later research refines what those clues mean.